subcutaneous Bortezomib May Reduce Adverse Effects in Multiple myeloma Subcutaneous (SC) bortezomib (Velcade; takeda Pharmaceuticals) may be associated with a lower incidence of peripheral neuropathy, infection, adn dyspepsia compared with …
Tag: